PRKCD and familial pancreatic carcinoma: The Ozpolat and Akar's group reported that 2–4 μM Rottlerin induced autophagy through inhibition of PKCδ/transglutaminase 2 (TG2) in a panel of pancreatic cancer cells that are known to be resistant to most chemotherapeutic agents [53, 54].